Broadwing Bio is advancing antibody therapies to treat common causes of vision loss. Focused on genetically validated targets, our goal is to develop best-in-disease therapies to meaningfully preserve eyesight for glaucoma and geographic atrophy patients.
| Website | https://www.broadwing.bio/ |
| Employees | 3 (2 on RocketReach) |
| Address | 171 Oyster Point Blvd Suite 300, South San Francisco, California 94080, US |
| Industry | Biotechnology Research |
| Keywords | Glaucoma Treatment, Ophthalmic Drugs, Eye Disease Treatment, Gene Therapy, Ocular Therapeutics, Biopharmaceutical, Rare Disease Treatment, Eye Medication, Ophthalmology, Vision Preservation, Drug Development, Clinical Trials, Biotechnology, Pharmaceutical Research, Retinal Diseases |
Looking for a particular Broadwing Bio employee's phone or email?
2 people are employed at Broadwing Bio.
Broadwing Bio is based in South San Francisco, California.